What would be the reason why DPP-4 competition is so fierce?
Handok has announced the launch of ‘Tenelia(generic name: teneligliptin),’ the 7th DPP-4 inhibitor. Its insurance price was selected as the lowest among other DPP-4 inhibitors with KRW 739. As JW Pharmaceutical acquired sales approval for the 8th DPP-4 inhibitor, ‘Gadret(generic name: anagliptin)...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
